By proceeding, you agree to our Terms of Use and Privacy Policy.
Meaningful progress in establishing causative genetic mutations and environmental factors implicated in ALS disease progression and advances in validating emerging biomarkers to evaluate treatment response has meant that the landscape for drug development in ALS is exploding.
Learn interesting industry processes from dissecting exciting progress in small molecules and gene therapy to clarifying sensitive primary outcome measures beyond ALSFRS-R.
Join industry experts from Biogen, Eli Lilly, Mitsubishi Tanabe Pharma, Sanofi, ProMIS Neurosciences, Cytokinetics, Brainstorm Cell Therapeutics and many more.
Propel your business towards unhindered success by learning how to drive progress towards slowed disease progression and improved outcomes in ALS.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
Founded by physicians committed to advancing medical science, Worldwide is out to change how the world experiences CROs – in the best possible way.
Genomenon is a genomic health IT company that keeps pace with the constant advancements made in genomics and connects that research to patient DNA to help diagnose and treat patients with rare genetic diseases and cancer.
At Julius Clinical, science is the foundation. Combined with flexibility, creativity, and innovation, our scientific approach enables fast, efficient, and high quality execution of complex clinical development programs.
We are a bunch of tech enthusiasts who deliver custom IT solutions in a predictable way. We help businesses bring their ideas to life from scratch, as well as rescue ongoing projects.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.